The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments
FDA Law
SEPTEMBER 20, 2021
From new initiatives to facilitate faster reviews for new indications under the Split Real Time Application Review (STAR) pilot program, to bringing new meetings under PDUFA goals, to continued support for rare diseases and incorporation of the patient voice, the goals letter revealed a good number of welcome announcements.
52 
Let's personalize your content